(Q44211958)

30 November 2017

Inhaled corticosteroids and systemic inflammatory response in community-acquired pneumonia: a prospective clinical study (English)

1 reference

30 November 2017

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24909304%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Paula Ramírez

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24909304%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Eva Polverino

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24909304%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Rosario Menéndez

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24909304%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

author name string

Miquel Ferrer

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24909304%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Raquel Martínez

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24909304%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Beatriz Montull

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24909304%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Salvador Sialer

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24909304%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Michael S Niederman

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24909304%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Alvar Agusti

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24909304%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

publication date

9 June 2014

1 reference

30 November 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24909304%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24909304%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24909304%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

page(s)

929-935

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24909304%20AND%20SRC:MED&resulttype=core&format=json

Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults

7 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12324

Novel nonantibiotic therapies for pneumonia: cytokines and host defense

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12324

Leucocyte response and anti-inflammatory cytokines in community acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12324

Biomarkers improve mortality prediction by prognostic scales in community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12324

Effects of systemic steroids in patients with severe community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12324

Corticosteroids in severe pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12324

Observational study of inhaled corticosteroids on outcomes for COPD patients with pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12324

Effects of fluticasone on systemic markers of inflammation in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12324

Influence of previous use of inhaled corticoids on the development of pleural effusion in community-acquired pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12324

A prediction rule to identify low-risk patients with community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12324

Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12324

The effects of inhaled and oral corticosteroids on serum inflammatory biomarkers in COPD: an exploratory study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12324

Macrophage activation in exacerbated COPD with and without community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12324

Defective macrophage phagocytosis of bacteria in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12324

Alternative activation of macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12324

Macrophage activation and polarization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12324

Risk factors of treatment failure in community acquired pneumonia: implications for disease outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12324

New perspectives on community-acquired pneumonia in 388 406 patients. Results from a nationwide mandatory performance measurement programme in healthcare quality

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12324

Effects of inhaled corticosteroids on pneumonia severity and antimicrobial resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12324

Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12324

Reported pneumonia in patients with COPD: findings from the INSPIRE study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12324

Long-term use of inhaled corticosteroids and the risk of pneumonia in chronic obstructive pulmonary disease: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12324

Inhaled corticosteroids in patients with stable chronic obstructive pulmonary disease: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12324

Pneumonia and pneumonia related mortality in patients with COPD treated with fixed combinations of inhaled corticosteroid and long acting β2 agonist: observational matched cohort study (PATHOS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12324

Budesonide and formoterol inhibit inflammatory mediator production by bronchial epithelial cells infected with rhinovirus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12324

21 January 2018

Identifiers

DOI

10.1111/RESP.12324

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24909304%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

1 reference